Skip to content

13F-HR/A filed by Ghost Tree Capital, LLC

Ghost Tree Capital, LLC filed this 13F-HR/A for the quarter ended 2018-09-30, filed 2020-04-09, with 55 holding rows worth $470,465,000.

Accession
0001387131-20-003798
Filed
2020-04-09
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2018

A holdings report, amendment of type restatement, 55 entries on the cover page, a total value of $470,465,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $470,465,000 with VALUE read as thousands by filing date, 13F file number 028-16059. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SPDR SER TR78464A870S&P BIOTECH500,000$47,935,000thousands by filing dateput
SAREPTA THERAPEUTICS INC803607100COM210,000$33,917,000thousands by filing date
PTC THERAPEUTICS INC69366J200COM500,000$23,500,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM435,300$20,503,000thousands by filing date
ENDOCYTE INC29269A102COM1,100,000$19,536,000thousands by filing date
IMMUNOMEDICS INC452907108COM883,823$18,410,000thousands by filing date
TESARO INC881569107COM450,000$17,555,000thousands by filing date
DICERNA PHARMACEUTICALS INC253031108COM1,100,000$16,786,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR225,000$15,944,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock175,000$15,316,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM300,000$14,130,000thousands by filing dateput
INVESCO CURRENCYSHARES SWISS46138R108SWISS FRANC128,700$12,266,000thousands by filing date
ASSEMBLY BIOSCIENCES INC045396108COM325,000$12,071,000thousands by filing date
BLUEBIRD BIO INC09609G100COM75,000$10,950,000thousands by filing date
ACADIA PHARMACEUTICALS INC004225108COM500,000$10,380,000thousands by filing date
ACADIA PHARMACEUTICALS INC004225108COM500,000$10,380,000thousands by filing datecall
RETROPHIN INC761299106COM350,000$10,056,000thousands by filing date
ZOGENIX INC.98978L204Common Stock200,000$9,920,000thousands by filing date
ROCKET PHARMACEUTICALS INC77313F106COM400,000$9,848,000thousands by filing date
ObsEva SAH5861P103COM535,000$9,646,000thousands by filing date
ARGENX SE SPONSORED ADR04016X101ADR125,000$9,480,000thousands by filing date
ZAFGEN INC98885E103COM750,000$8,768,000thousands by filing date
PORTOLA PHARMACEUTICALS INC COM737010108Stock300,000$7,989,000thousands by filing date
TRICIDA INC89610F101COM250,000$7,638,000thousands by filing date
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM200,000$7,510,000thousands by filing date
Viewra, Inc92672L107COM750,000$7,020,000thousands by filing date
KADMON HLDGS INC48283N106COM2,000,000$6,680,000thousands by filing date
ANAPTYSBIO INC032724106COM60,000$5,986,000thousands by filing date
GLYCOMIMETICS INC38000Q102COM400,000$5,760,000thousands by filing date
GLOBAL BLOOD THERAPEUTICS USD37890U108COM150,000$5,700,000thousands by filing datecall
KALVISTA PHARMACEUTICALS INC483497103COM225,000$4,975,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock50,000$4,376,000thousands by filing datecall
BIODELIVERY SCIENCES INTL IN09060J106COM1,500,000$4,200,000thousands by filing date
KURA ONCOLOGY INC COM50127T109Stock230,000$4,025,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock500,000$3,815,000thousands by filing date
UROVANT SCIENCESG9381B108COMMON STOCK300,000$3,600,000thousands by filing date
RADIUS HEALTH INC750469207COM NEW200,000$3,560,000thousands by filing date
ALLAKOS INC01671P100COM75,000$3,374,000thousands by filing date
APELLIS PHARMACEUTICALS INC03753U106COM185,000$3,289,000thousands by filing date
MADRIGAL PHARMACEUTICALS INC COM558868105Stock14,200$3,041,000thousands by filing date
ARVINAS INC04335A105COM175,000$2,952,000thousands by filing date
GENOCEA BIOSCIENCES INC372427104COM3,525,000$2,748,000thousands by filing date
NEOS THERAPEUTICS INC64052L106COM482,600$2,341,000thousands by filing date
CATALYST BIOSCIENCES INC14888D208COM200,000$2,156,000thousands by filing date
AVADEL PHARMACEUTICALS, PLC05337M104COMMON STOCK-FO450,000$1,976,000thousands by filing date
AQUINOX PHARMACEUTICALS INC03842B101COM500,000$1,465,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM9,500$1,342,000thousands by filing date
FATE THERAPEUTICS INC31189P102COM75,000$1,222,000thousands by filing date
GRITSTONE BIO INC39868T105COM75,000$1,068,000thousands by filing date
EDGE THERAPEUTICS INC279870109COM1,000,000$820,000thousands by filing date
SPECTRUM PHARMACEUTICALS INC84763A108COM47,200$793,000thousands by filing date
INSMED INC COM PAR $.01457669307Stock26,000$526,000thousands by filing date
MOTUS GI HLDGS INC62014P108COM100,000$510,000thousands by filing date
GLOBAL BLOOD THERAPEUTICS USD37890U108COM12,000$456,000thousands by filing date
TG THERAPEUTICS INC COM88322Q108Stock45,500$255,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001387131-18-006157 superseded2018-11-14acceptance time not in the bulk data set
13F-HR/A 0001387131-20-003798this filing2020-04-09acceptance time not in the bulk data set